FDA Approves First Generic Truvada in US

FDA Approves First Generic Truvada in US

June 09, 2017

 

UPDATED June 9, 2017 // The US Food and Drug Administration (FDA) has approved the first generic version of emtricitabine/tenofovir disoproxil (Truvada, Gilead Sciences) to both treat and prevent HIV infections in this country, the agency announced today.

The manufacturer of the generic is Teva Pharmaceutical Industries. However, the leader of an HIV prevention organization told Medscape Medical News that more generic drug makers are likely to introduce their versions of emtricitabine/tenofovir disoproxil.

FULL STORY: http://www.medscape.com/viewarticle/881368

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s